Innovation Pharmaceuticals Inc (IPIX)

[frrol]

FWIW, P is part of my IPIX investment thesis. I think the great preclinical results are justification for hope in our clinical Phase 2A, as are the tiny signal in the 200mg arm. I will readily admit that preclinicals and a small 200mg clinical arm are not reliable "proof" of anything, but nor do I deny that we are facing risks with P. I think you are over reacting to penny stock speculators who are not experienced in biotech. (And I am not referring to Plenty, btw).